Benkhaled Sofian, Van Gestel Dirk, Gomes da Silveira Cauduro Carolina, Palumbo Samuel, Del Marmol Veronique, Desmet Antoine
Department of Radiation-Oncology, Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
Department of Radiation-Oncology, Jolimont Hospital, La Louvière, Belgium.
Front Med (Lausanne). 2022 Jun 27;9:913269. doi: 10.3389/fmed.2022.913269. eCollection 2022.
Due to the general aging population and the fashion trend of sun exposure, non-melanoma skin cancer (NMSC) is rising. The management of NMSC is difficult and necessitates a multidisciplinary team (i.e., pathologists, dermatologists, medical oncologists, surgeons, and radiation oncologists). When surgery is not an option or will cause unacceptably functional morbidity, radiation therapy (RT) may be a preferable tissue-preserving option. Whether used alone or in conjunction with other treatments, RT has been shown to be quite effective in terms of cosmetic results and local control. Contact hypofractionated RT, brachytherapy, and electronic brachytherapy are all promising new treatments. However, rigorous, randomized trials are missing, explaining the disparity in dose, fractionation, and technique recommendations. Therefore, it is essential that interdisciplinary teams better understand RT modalities, benefits, and drawbacks. Our review will provide the role and indications for RT in patients with NMSC.
由于人口普遍老龄化以及阳光照射的时尚趋势,非黑色素瘤皮肤癌(NMSC)的发病率正在上升。NMSC的治疗具有挑战性,需要多学科团队(即病理学家、皮肤科医生、医学肿瘤学家、外科医生和放射肿瘤学家)参与。当手术不可行或会导致不可接受的功能损害时,放射治疗(RT)可能是一种更可取的保留组织的选择。无论是单独使用还是与其他治疗联合使用,RT在美容效果和局部控制方面都已被证明相当有效。接触式低分割放疗、近距离放疗和电子近距离放疗都是很有前景的新治疗方法。然而,缺乏严格的随机试验,这解释了在剂量、分割方式和技术建议方面存在的差异。因此,跨学科团队必须更好地了解放疗方式、益处和缺点。我们的综述将阐述放疗在NMSC患者中的作用和适应证。